Active Biomarkers is an integrated bioanalytical laboratory offering multiple in-vitro immunology services: Pharmacokinetics, Immunogenicity, Receptor Occupancy assays, and soluble/cellular biomarkers monitoring.

Operating in BSL2 facilities, and GCLP/ISO 9001:2015 environment, the company currently employs 30 people bringing a wealth of experience in the development, validation, and implementation of analytical methods. Its know-how is recognized in 4 major therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases.

Beyond its state-of-the-art flow cytometry and ELISpot capabilities, Active Biomarkers offers the broadest panel of immunoassay technologies in Europe, ranging from standard ELISA to multiplexed methods such as Luminex, SP-X, Gyros or ELLA systems, and ultra-sensitive technologies such as MSD or Simoa HD-1.